Voyager Therapeutics, Inc. Comprehensive Income
Voyager Therapeutics, Inc. (VYGR) reported Comprehensive Income of -$24.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$24.63M.
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$28.23M.
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$27.40M.
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$27.66M.
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$119.28M.
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$65.36M, a 149.33% decline from fiscal 2023.
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $132.50M.
- Voyager Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$46.49M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$24.63M 10-Q · filed 2026-08-06 | -$52.86M 10-Q · filed 2026-08-06 | -$80.26M derived: sum of 3 quarters · filed 2026-08-06 | -$107.93M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | -$28.23M 10-Q · filed 2026-05-07 | -$55.63M derived: sum of 2 quarters · filed 2026-05-07 | -$83.30M derived: sum of 3 quarters · filed 2026-05-07 | -$116.70M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | -$27.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$55.06M derived: sum of 2 quarters · filed 2026-03-09 | -$88.47M derived: sum of 3 quarters · filed 2026-08-06 | -$119.28M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | -$27.66M 10-Q · filed 2025-11-10 | -$61.07M derived: sum of 2 quarters · filed 2026-08-06 | -$91.88M 10-Q · filed 2025-11-10 | -$126.74M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | -$33.40M 10-Q · filed 2026-08-06 | -$64.22M 10-Q · filed 2026-08-06 | -$99.08M derived: sum of 3 quarters · filed 2026-08-06 | -$107.63M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | -$30.81M 10-Q · filed 2026-05-07 | -$65.67M derived: sum of 2 quarters · filed 2026-05-07 | -$74.23M derived: sum of 3 quarters · filed 2026-05-07 | -$84.39M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | -$34.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$43.42M derived: sum of 2 quarters · filed 2026-03-09 | -$53.57M derived: sum of 3 quarters · filed 2026-03-09 | -$65.36M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | -$8.55M 10-Q · filed 2025-11-10 | -$18.71M derived: sum of 2 quarters · filed 2025-11-10 | -$30.50M 10-Q · filed 2025-11-10 | $26.09M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-06-30 | -$10.16M 10-Q · filed 2025-08-06 | -$21.95M 10-Q · filed 2025-08-06 | $34.65M derived: sum of 3 quarters · filed 2026-03-09 | $8.63M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2024-03-31 | -$11.79M 10-Q · filed 2025-05-06 | $44.81M derived: sum of 2 quarters · filed 2026-03-09 | $18.79M derived: sum of 3 quarters · filed 2026-03-09 | -$3.42M derived: sum of 4 quarters · filed 2026-03-09 | |||
| 2023-12-31 | $56.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $30.58M derived: sum of 2 quarters · filed 2026-03-09 | $8.37M derived: sum of 3 quarters · filed 2026-03-09 | $132.50M 10-K · filed 2026-03-09 | |||
| 2023-09-30 | -$26.02M 10-Q · filed 2024-11-12 | -$48.23M derived: sum of 2 quarters · filed 2024-11-12 | $75.91M 10-Q · filed 2024-11-12 | $52.40M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-06-30 | -$22.21M 10-Q · filed 2024-08-06 | $101.92M 10-Q · filed 2024-08-06 | $78.41M derived: sum of 3 quarters · filed 2025-03-11 | $96.06M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-03-31 | $124.13M 10-Q · filed 2024-05-13 | $100.62M derived: sum of 2 quarters · filed 2025-03-11 | $118.27M derived: sum of 3 quarters · filed 2025-03-11 | $99.05M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2022-12-31 | -$23.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$5.86M derived: sum of 2 quarters · filed 2025-03-11 | -$25.09M derived: sum of 3 quarters · filed 2025-03-11 | -$46.49M 10-K · filed 2025-03-11 | |||
| 2022-09-30 | $17.65M 10-Q · filed 2023-11-06 | -$1.58M derived: sum of 2 quarters · filed 2023-11-06 | -$22.98M 10-Q · filed 2023-11-06 | -$17.28M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-06-30 | -$19.23M 10-Q · filed 2023-08-03 | -$40.63M 10-Q · filed 2023-08-03 | -$34.93M derived: sum of 3 quarters · filed 2024-02-28 | -$60.07M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2022-03-31 | -$21.40M 10-Q · filed 2023-05-09 | -$15.71M derived: sum of 2 quarters · filed 2024-02-28 | -$40.84M derived: sum of 3 quarters · filed 2024-02-28 | -$70.97M derived: sum of 4 quarters · filed 2024-02-28 | |||
| 2021-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$19.44M derived: sum of 2 quarters · filed 2024-02-28 | -$49.56M derived: sum of 3 quarters · filed 2024-02-28 | -$71.20M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | -$25.14M 10-Q · filed 2022-11-08 | -$55.26M derived: sum of 2 quarters · filed 2022-11-08 | -$76.90M 10-Q · filed 2022-11-08 | -$92.90M derived: sum of 4 quarters · filed 2023-03-07 | |||
| 2021-06-30 | -$30.12M 10-Q · filed 2022-08-04 | -$51.76M 10-Q · filed 2022-08-04 | -$67.76M derived: sum of 3 quarters · filed 2023-03-07 | $17.64M derived: sum of 4 quarters · filed 2023-03-07 | |||
| 2021-03-31 | -$21.64M 10-Q · filed 2022-05-04 | -$37.64M derived: sum of 2 quarters · filed 2023-03-07 | $47.77M derived: sum of 3 quarters · filed 2023-03-07 | $38.81M derived: sum of 4 quarters · filed 2023-03-07 | |||
| 2020-12-31 | -$16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $69.41M derived: sum of 2 quarters · filed 2023-03-07 | $60.45M derived: sum of 3 quarters · filed 2023-03-07 | $36.71M 10-K · filed 2023-03-07 | |||
| 2020-09-30 | $85.41M 10-Q · filed 2021-11-02 | $76.45M derived: sum of 2 quarters · filed 2021-11-02 | $52.71M 10-Q · filed 2021-11-02 | $40.05M derived: sum of 4 quarters · filed 2022-03-08 | |||
| 2020-06-30 | -$8.96M 10-Q · filed 2021-08-09 | -$32.70M 10-Q · filed 2021-08-09 | -$45.36M derived: sum of 3 quarters · filed 2022-03-08 | -$60.48M derived: sum of 4 quarters · filed 2022-03-08 | |||
| 2020-03-31 | -$23.74M 10-Q · filed 2021-05-10 | -$36.40M derived: sum of 2 quarters · filed 2022-03-08 | -$51.52M derived: sum of 3 quarters · filed 2022-03-08 | -$40.19M derived: sum of 4 quarters · filed 2022-03-08 | |||
| 2019-12-31 | -$12.66M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$27.79M derived: sum of 2 quarters · filed 2022-03-08 | -$16.46M derived: sum of 3 quarters · filed 2022-03-08 | -$43.57M 10-K · filed 2022-03-08 | |||
| 2019-09-30 | -$15.12M 10-Q · filed 2020-11-09 | -$3.79M derived: sum of 2 quarters · filed 2020-11-09 | -$30.91M 10-Q · filed 2020-11-09 | -$53.52M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $11.33M 10-Q · filed 2020-08-10 | -$15.78M 10-Q · filed 2020-08-10 | -$38.39M derived: sum of 3 quarters · filed 2021-02-25 | -$58.73M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$27.11M 10-Q · filed 2020-05-06 | -$49.72M derived: sum of 2 quarters · filed 2021-02-25 | -$70.06M derived: sum of 3 quarters · filed 2021-02-25 | -$95.56M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | -$22.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$42.95M derived: sum of 2 quarters · filed 2021-02-25 | -$68.45M derived: sum of 3 quarters · filed 2021-02-25 | -$88.25M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | -$20.34M 10-Q · filed 2019-11-06 | -$45.84M derived: sum of 2 quarters · filed 2019-11-06 | -$65.64M 10-Q · filed 2019-11-06 | -$65.65M 10-Q · filed 2018-11-07 | -$77.30M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-06-30 | -$25.50M 10-Q · filed 2019-08-09 | -$45.31M 10-Q · filed 2019-08-09 | -$45.31M 10-Q · filed 2018-08-07 | -$56.97M derived: sum of 3 quarters · filed 2020-03-03 | -$80.80M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2018-03-31 | -$19.80M 10-Q · filed 2019-05-07 | -$19.81M 10-Q · filed 2018-05-10 | -$31.46M derived: sum of 2 quarters · filed 2020-03-03 | -$55.29M derived: sum of 3 quarters · filed 2020-03-03 | -$74.46M derived: sum of 4 quarters · filed 2020-03-03 | ||
| 2017-12-31 | -$11.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$35.49M derived: sum of 2 quarters · filed 2020-03-03 | -$54.66M derived: sum of 3 quarters · filed 2020-03-03 | -$70.93M 10-K · filed 2020-03-03 | |||
| 2017-09-30 | -$23.83M 10-Q · filed 2018-11-07 | -$43.00M derived: sum of 2 quarters · filed 2018-11-07 | -$59.27M 10-Q · filed 2018-11-07 | -$74.63M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | -$19.17M 10-Q · filed 2018-08-07 | -$35.44M 10-Q · filed 2018-08-07 | -$50.80M derived: sum of 3 quarters · filed 2019-02-26 | -$59.22M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$16.27M 10-Q · filed 2018-05-10 | -$31.63M derived: sum of 2 quarters · filed 2019-02-26 | -$40.05M derived: sum of 3 quarters · filed 2019-02-26 | -$49.36M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$15.36M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$23.78M derived: sum of 2 quarters · filed 2019-02-26 | -$33.09M derived: sum of 3 quarters · filed 2019-02-26 | -$39.99M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | -$8.43M 10-Q · filed 2017-11-02 | -$17.73M derived: sum of 2 quarters · filed 2017-11-02 | -$24.64M 10-Q · filed 2017-11-02 | -$32.21M derived: sum of 4 quarters · filed 2018-03-14 | |||
| 2016-06-30 | -$9.30M 10-Q · filed 2017-08-08 | -$16.21M 10-Q · filed 2017-08-08 | -$23.78M derived: sum of 3 quarters · filed 2018-03-14 | -$27.64M derived: sum of 4 quarters · filed 2018-03-14 | |||
| 2016-03-31 | -$6.91M 10-Q · filed 2017-05-09 | -$14.48M derived: sum of 2 quarters · filed 2018-03-14 | -$18.34M derived: sum of 3 quarters · filed 2018-03-14 | -$22.25M derived: sum of 4 quarters · filed 2018-03-14 | |||
| 2015-12-31 | -$7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$11.43M derived: sum of 2 quarters · filed 2018-03-14 | -$15.35M derived: sum of 3 quarters · filed 2018-03-14 | -$29.92M 10-K · filed 2018-03-14 | |||
| 2015-09-30 | -$3.86M 10-Q · filed 2016-11-10 | -$7.77M derived: sum of 2 quarters · filed 2016-11-10 | -$22.35M 10-Q · filed 2016-11-10 | -$27.04M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-06-30 | -$3.92M 10-Q · filed 2016-08-11 | -$18.49M 10-Q · filed 2016-08-11 | -$23.18M derived: sum of 3 quarters · filed 2017-03-15 | -$27.19M derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-03-31 | -$14.58M 10-Q · filed 2016-05-12 | -$19.27M derived: sum of 2 quarters · filed 2017-03-15 | -$23.27M derived: sum of 3 quarters · filed 2017-03-15 | ||||
| 2014-12-31 | -$4.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$8.70M derived: sum of 2 quarters · filed 2017-03-15 | -$16.32M 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | -$4.00M 10-Q · filed 2015-12-17 | -$11.63M 10-Q · filed 2015-12-17 | |||||
| 2013-12-31 | -$3.83M 10-K · filed 2016-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |